logo
Select company
Select metric
-229.8%Return on Equity
VS
Market
6
Sector
17
Industry
20
History
22
$ 5.62Close
$ 3.81 - $ 9.02 52-Week Range
Ticker Information

Ticker

DTIL

Company Name

PRECISION BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PRECISION BIOSCIENCES INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DTIL - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 34.05M$ -78.25M-229.8%
3/31/2025$ 49.34M$ -21.99M-44.56%
12/31/2024$ 56.39M$ 7.17M12.71%
9/30/2024$ 64.87M$ 8.62M13.29%
6/30/2024$ 74.71M$ 16.97M22.71%
3/31/2024$ 37.21M$ -27.67M-74.37%
12/31/2023$ 18.86M$ -61.32M-325.11%
9/30/2023$ 29.06M$ -73.52M-252.96%
6/30/2023$ 34.04M$ -89.39M-262.58%
3/31/2023$ 40.18M$ -108.53M-270.13%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PRECISION BIOSCIENCES INC's latest trailing twelve months (TTM) ROE stands at -166.82%.
  • Over the past 5 years, PRECISION BIOSCIENCES INC's average ROE has been -128.14%.
  • The median ROE for PRECISION BIOSCIENCES INC during this period was -107.5%
  • PRECISION BIOSCIENCES INC reached its highest ROE over the past 5 years at 22.71%.
  • The lowest ROE recorded by PRECISION BIOSCIENCES INC in the same timeframe -325.11%

PRECISION BIOSCIENCES INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
ADVM : ADVERUM BIOTECHNOLOGIES INC -RANI : RANI THERAPEUTICS HOLDINGS INC -PLUR : PLURI INC -IGC : IGC PHARMA INC -104.34%CLSD : CLEARSIDE BIOMEDICAL INC -RNXT : RENOVORX INC -100.22%LSTA : LISATA THERAPEUTICS INC -89.99%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -COEP : COEPTIS THERAPEUTICS HOLDINGS INC -170.1%SER : SERINA THERAPEUTICS INC -698.72%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for PRECISION BIOSCIENCES INC is calculated as follows: Net Inc. Cmn. [ $ -106.47M ] / Equity [ $ 63.82M ]
(=) ROE [ -166.82% ]

DTIL - Return on Equity, Last 5 years

-325.11%

Minimum

Dec 31, 2023

22.71%

Maximum

Jun 30, 2024

-128.14%

Average

-107.5%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%